Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

ClinicalTrials.gov ID: NCT07298473

Public ClinicalTrials.gov record NCT07298473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 7, 2026, 5:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Conquer-AF is a prospective, multi-center, interventional, non-randomized clinical study that will enroll up to 400 subjects at up to 30 sites across the United States, Europe, and Australia. Subjects diagnosed with symptomatic recurrent paroxysmal or persistent atrial fibrillation after a single prior ablation procedure will be enrolled in this study. Each subject will undergo a study index redo ablation procedure using the Sphere-9 Catheter and Affera Ablation System and will be followed for 12 months. The expected total study duration (from time of first enrollment to the exit of last enrolled subject) is approximately 2 years.

Study identification

NCT ID
NCT07298473
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Enrollment
400 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2026
Primary completion
Mar 28, 2028
Completion
Mar 28, 2028
Last update posted
Jul 30, 2026

2026 – 2028

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
22
Facility City State ZIP Site status
University of Alabama at Birmingham (UAB) Hospital Birmingham Alabama 35233 Recruiting
Scripps Green Hospital La Jolla California 92037 Not yet recruiting
Cedars Sinai Medical Center Los Angeles California 90048-1804 Recruiting
NCH Rooney Heart Institute Naples Florida 34102 Recruiting
AdventHealth Cardiovascular Research Institute Orlando Florida 32803 Not yet recruiting
Piedmont Heart Institute Atlanta Georgia 30309 Recruiting
Memorial Health University Medical Center Savannah Georgia 31404 Recruiting
Massachusetts General Hospital Boston Massachusetts 02114-2621 Recruiting
Kansas City Heart Rhythm Institute (Midwest Heart and Vascular Specialist) Kansas City Missouri 64111 Not yet recruiting
Northwell Health Lenox Hill Hospital New Hyde Park New York 11040-1402 Recruiting
NYU Langone Health New York New York 10016-4972 Recruiting
Montefiore Medical Center The Bronx New York 10467 Recruiting
Cleveland Clinic Foundation Cleveland Ohio 44195 Recruiting
OhioHealth Research and Innovation Institute (OHRI) Columbus Ohio 43214-3467 Recruiting
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 Recruiting
Allegheny General Hospital Pittsburgh Pennsylvania 15212-4756 Recruiting
Vanderbilt University Medical Center Nashville Tennessee 37232-0019 Recruiting
Texas Cardiac Arrhythmia Research Foundation Dallas Texas 75226 Recruiting
Texas Health Fort Worth Fort Worth Texas 76104 Recruiting
Inova Fairfax Hospital Falls Church Virginia 22042 Recruiting
Centra Medical Group Stroobants Cardiovascular Center Lynchburg Virginia 24501 Recruiting
Sentara Norfolk General Hospital Newport News Virginia 23606-2981 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07298473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07298473 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →